Skip to main content
Lifevantage Corp logo

Lifevantage Corp — Investor Relations & Filings

Ticker · LFVN ISIN · US53222K2050 LEI · 5493001Z5YYT109QZ980 US Manufacturing
Filings indexed 1,019 across all filing types
Latest filing 2026-05-06 Report Publication Anno…
Country US United States of America
Listing US LFVN

About Lifevantage Corp

https://www.lifevantage.com/

LifeVantage Corporation is a science-based company specializing in nutrigenomics, the study of how nutrition and naturally occurring compounds affect gene expression. The company researches, develops, formulates, and sells advanced nutraceuticals and dietary supplements designed to support health and wellness. Its core product philosophy centers on the concept of "activation," aiming to support the body's natural cellular processes. A key product line is Protandim, a dietary supplement developed based on the company's nutrigenomic research. The company distributes its products through a network marketing model.

Recent filings

Filing Released Lang Actions
8-K
Report Publication Announcement Classification · 90% confidence The document is a Form 8-K current report (under Section 13/15(d)) notifying investors that the company issued a press release announcing its quarterly financial results, with the press release attached as Exhibit 99.1. It does not contain the actual financial data itself but rather informs readers that the report (press release) has been published and is furnished herewith. Under the “Menu vs Meal” rule, short documents stating a report is attached are classified as Report Publication Announcements (RPA), not as the report itself (ER or IR).
2026-05-06 English
10-Q
Interim / Quarterly Report Q3 2026
2026-05-06 English
8-K - Lifevantage Corp (0000849146) (Filer)
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content focuses on the departure of the CEO, appointment of a new CEO, interim CEO appointment, and related employment and transition agreements. There are no financial statements or detailed financial performance data presented. The primary subject is changes in senior management and board composition. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is sufficient and contains detailed information about management changes, not just a brief announcement or a report publication notice. Therefore, the correct classification is MANG with high confidence.
2026-04-16 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-02 English
EFFECT - Lifevantage Corp (0000849146) (Filer)
Regulatory Filings
2026-03-23 English
S-3
Regulatory Filings
2026-03-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.